{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:03:49Z","timestamp":1794269029204,"version":"4.9.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T00:00:00Z","timestamp":1577059200000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>To determine the frequency and clinical characteristics of systemic sclerosis-related digital ulcers, and associated direct health care costs, quality of life, and survival.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Digital ulcers (DUs) were defined as an area with a visually discernible depth and a loss of continuity of epithelial coverage. DU severity was calculated based on the physician reported highest number of new DUs at clinical review (mild\u2009=\u20091\u20135 DUs, moderate 6\u201310 DUs, severe &gt;\u200910 DUs). Healthcare use was captured through data linkage, wherein SSc clinical data captured prospectively in a dedicated clinical database were linked with health services databases to capture hospital admissions, emergency department (ED) presentations and ambulatory care (MBS) utilization and cost for the period 2008\u20132015. Healthcare cost determinants were estimated using logistic regression.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Among 1085 SSc patients, 48.6% experienced a DU over a mean follow-up of 5.2\u2009\u00b1\u20092.5\u2009years. Those who developed DUs were more likely to have diffuse disease subtype (34.9% vs 18.2%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), anti-Scl-70 antibody (18.9% vs 9.3%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), and a younger age at SSc onset (43.6\u2009\u00b1\u200913.9 vs 48.8\u2009\u00b1\u200914.0\u2009years, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) in addition to reduced health-related quality of life (HRQoL) measured by the SF-36 but without a significant impact on survival. SSc patients with a history of a DU utilized significantly more healthcare resources per annum than those without a DU, including hospitalizations, ED presentation, and ambulatory care services. Total healthcare services, excluding medications, were associated with an annual excess cost per DU patient of AUD$12,474 (8574-25,677), <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001, driven by hospital admission and ED presentation costs.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>DUs place a large burden on the patient and healthcare system through reduced HRQoL and increased healthcare resource utilization and associated cost.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13075-019-2080-y","type":"journal-article","created":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T15:02:39Z","timestamp":1577113359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Digital ulcers in systemic sclerosis: their epidemiology, clinical characteristics, and associated clinical and economic burden"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3840-3967","authenticated-orcid":false,"given":"Kathleen","family":"Morrisroe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Sahhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene-Siew","family":"Ngian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nava","family":"Ferdowsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine L.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Roddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Proudman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Nikpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,23]]},"reference":[{"issue":"4","key":"2080_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.semarthrit.2007.05.003","volume":"37","author":"H Chifflot","year":"2008","unstructured":"Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J. Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum. 2008;37(4):223\u201335.","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"2080_CR2","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00281-015-0505-5","volume":"37","author":"Y Asano","year":"2015","unstructured":"Asano Y, Sato S. Vasculopathy in scleroderma. Semin Immunopathol. 2015;37(5):489\u2013500.","journal-title":"Semin Immunopathol"},{"issue":"3","key":"2080_CR3","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.rdc.2015.04.005","volume":"41","author":"L Cappelli","year":"2015","unstructured":"Cappelli L, Wigley FM. Management of Raynaud Phenomenon and Digital Ulcers in scleroderma. Rheum Dis Clin N Am. 2015;41(3):419\u201338.","journal-title":"Rheum Dis Clin N Am"},{"issue":"3","key":"2080_CR4","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1756-185X.2009.01410.x","volume":"12","author":"G Strange","year":"2009","unstructured":"Strange G, Nash P. The manifestations of vasculopathy in systemic sclerosis and its evidence-based therapy. Int J Rheum Dis. 2009;12(3):192\u2013206.","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"2080_CR5","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/rheumatology\/kew047","volume":"56","author":"M Hughes","year":"2017","unstructured":"Hughes M, Herrick AL. Digital ulcers in systemic sclerosis. Rheumatology (Oxford). 2017;56(1):14\u201325.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"2080_CR6","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/annrheumdis-2014-205897","volume":"75","author":"C Mihai","year":"2016","unstructured":"Mihai C, Landewe R, van der Heijde D, Walker UA, Constantin PI, Gherghe AM, Ionescu R, Rednic S, Allanore Y, Avouac J, et al. Digital ulcers predict a worse disease course in patients with systemic sclerosis. Ann Rheum Dis. 2016;75(4):681\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2080_CR7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/rheumatology\/keu296","volume":"54","author":"C Bruni","year":"2015","unstructured":"Bruni C, Guiducci S, Bellando-Randone S, Lepri G, Braschi F, Fiori G, Bartoli F, Peruzzi F, Blagojevic J, Matucci-Cerinic M. Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis. Rheumatology (Oxford). 2015;54(1):72\u20136.","journal-title":"Rheumatology (Oxford)"},{"issue":"2 Suppl 76","key":"2080_CR8","first-page":"71","volume":"31","author":"L Guillevin","year":"2013","unstructured":"Guillevin L, Hunsche E, Denton CP, Krieg T, Schwierin B, Rosenberg D, Matucci-Cerinic M. Functional impairment of systemic scleroderma patients with digital ulcerations: results from the DUO registry. Clin Exp Rheumatol. 2013;31(2 Suppl 76):71\u201380.","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"2080_CR9","first-page":"2423","volume":"34","author":"E Hachulla","year":"2007","unstructured":"Hachulla E, Clerson P, Launay D, Lambert M, Morell-Dubois S, Queyrel V, Hatron PY. Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study. J Rheumatol. 2007;34(12):2423\u201330.","journal-title":"J Rheumatol"},{"issue":"7","key":"2080_CR10","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1136\/annrheumdis-2015-207271","volume":"75","author":"EG Wirz","year":"2016","unstructured":"Wirz EG, Jaeger VK, Allanore Y, Riemekasten G, Hachulla E, Distler O, Airo P, Carreira PE, Tikly M, Vettori S, et al. Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database. Ann Rheum Dis. 2016;75(7):1285\u201392.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"2080_CR11","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72(11):1747\u201355.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"2080_CR12","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.5603\/KP.2015.0242","volume":"73","author":"N Galie","year":"2015","unstructured":"Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, et al. 2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Kardiol Pol. 2015;73(12):1127\u2013206.","journal-title":"Kardiol Pol"},{"issue":"6","key":"2080_CR13","first-page":"1117","volume":"33","author":"SR Johnson","year":"2006","unstructured":"Johnson SR, Glaman DD, Schentag CT, Lee P. Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases. J Rheumatol. 2006;33(6):1117\u201322.","journal-title":"J Rheumatol"},{"key":"2080_CR14","unstructured":"Specialist clinics in Victorian Public Hospitals: a resource kit for MBS-biled services http:\/\/www.health.vic.gov.au\/divisions\/hhsp\/fundin. Accessed 23 Feb 2017"},{"issue":"2","key":"2080_CR15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/00005792-200203000-00004","volume":"81","author":"C Ferri","year":"2002","unstructured":"Ferri C, Valentini G, Cozzi F, Sebastiani M, Michelassi C, La Montagna G, Bullo A, Cazzato M, Tirri E, Storino F, et al. Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine. 2002;81(2):139\u201353.","journal-title":"Medicine"},{"issue":"6","key":"2080_CR16","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1136\/ard.2006.062901","volume":"66","author":"UA Walker","year":"2007","unstructured":"Walker UA, Tyndall A, Czirjak L, Denton C, Farge-Bancel D, Kowal-Bielecka O, Muller-Ladner U, Bocelli-Tyndall C, Matucci-Cerinic M. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR scleroderma trials and research group database. Ann Rheum Dis. 2007;66(6):754\u201363.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"2080_CR17","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/j.1365-2133.2008.09004.x","volume":"160","author":"C Sunderkotter","year":"2009","unstructured":"Sunderkotter C, Herrgott I, Bruckner C, Moinzadeh P, Pfeiffer C, Gerss J, Hunzelmann N, Bohm M, Krieg T, Muller-Ladner U, et al. Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors. Br J Dermatol. 2009;160(4):835\u201343.","journal-title":"Br J Dermatol"},{"issue":"1","key":"2080_CR18","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/acr.20336","volume":"63","author":"S Khimdas","year":"2011","unstructured":"Khimdas S, Harding S, Bonner A, Zummer B, Baron M, Pope J. Associations with digital ulcers in a large cohort of systemic sclerosis: results from the Canadian scleroderma research group registry. Arthritis care & research. 2011;63(1):142\u20139.","journal-title":"Arthritis care & research"},{"issue":"1","key":"2080_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/ard.2007.072686","volume":"67","author":"SI Nihtyanova","year":"2008","unstructured":"Nihtyanova SI, Brough GM, Black CM, Denton CP. Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis. 2008;67(1):120\u20133.","journal-title":"Ann Rheum Dis"},{"issue":"4 Suppl 91","key":"2080_CR20","first-page":"S47","volume":"33","author":"M Brand","year":"2015","unstructured":"Brand M, Hollaender R, Rosenberg D, Scott M, Hunsche E, Tyndall A, Denaro V, Carreira P, Varju C, Gabrielli B, et al. An observational cohort study of patients with newly diagnosed digital ulcer disease secondary to systemic sclerosis registered in the EUSTAR database. Clin Exp Rheumatol. 2015;33(4 Suppl 91):S47\u201354.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"2080_CR21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jbspin.2009.05.015","volume":"77","author":"F Cozzi","year":"2010","unstructured":"Cozzi F, Tiso F, Lopatriello S, Ciprian L, Sfriso P, Berto P, Punzi L. The social costs of digital ulcer management in sclerodema patients: an observational Italian pilot study. Joint Bone Spine. 2010;77(1):83\u20134.","journal-title":"Joint Bone Spine"},{"key":"2080_CR22","unstructured":"Morrisroe K, Hudson M, Baron M, de Vries-Bouwstra J, Carreira PE, Wuttge DM, Wang M, Frech TM, Stevens W, Proudman SM, et al. Determinants of health-related quality of life in a multinational systemic sclerosis inception cohort. Clin Exp Rheumatol. 2018;36(4):53\u201360."}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-2080-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-019-2080-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-019-2080-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T00:27:39Z","timestamp":1608596859000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-019-2080-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2080"],"URL":"https:\/\/doi.org\/10.1186\/s13075-019-2080-y","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"4 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written consent from all patients was obtained prior to study commencement.Ethical approval from all participating hospitals was obtained prior to study commencement.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All data used in this study has obtained patient consent for publication.All authors have read and approved this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"299"}}